APC and neoplasm: In an in vivo model of intestinal adenoma where adenomatous polyposis coli (APC) is deleted in LGR5+ intestinal stem cells, TIGAR deficiency decreases tumour burden and average tumour size, which results in increased disease-free survival in these mice.